For example, the effects of bezafibrate, a compound that activates PGC-1α/PPAR complexes in combination with anti-PD-1 therapy, were examined in cancer models.471 The results showed that bezafibrate activated the mitochondria of cytotoxic T lymphocytes, promoting oxidative phosphorylation and glycolysis. This evidence concerns the gene PDCD1 and cancer.